We are thrilled to be an exhibitor at the ADCES Diabetes Technology Conference (DTC25) in Chicago on December 12 and 13. This unique event focuses on how cutting-edge technology, like Glooko, can empower diabetes care teams and improve outcomes for people with diabetes.
During the show, we’ll share at table #18 how Glooko delivers essential clinical advantages. Attendees will see firsthand how our diabetes management software, compatible with more than 200 diabetes and health monitoring devices and apps, enables care teams to effortlessly analyze patient data, streamline care coordination, and tailor interventions that can lead to improved health outcomes.
Here’s what we’ll showcase at DTC25:
- New Glooko Clinic Dashboard: Designed specifically for busy healthcare providers, the new dashboard in Glooko offers an organized, at-a-glance view of patient trends and crucial clinic metrics. This powerful tool enables care teams to make more informed treatment decisions and build a stronger clinic strategy.
- Seamless EHR Integrations: Glooko streamlines clinical workflows by integrating securely with leading EHR systems. This functionality eliminates the need for healthcare providers to switch platforms, giving care teams a complete, centralized view of all diabetes and related health data within a single, familiar interface, allowing them to work more efficiently.
- EndoTool Glucose Management System, developed by Monarch Medical Technologies, a Glooko Company: Recently acquired by Glooko, EndoTool is the leading patient-specific inpatient insulin-dosing software trusted by 8 of the top 10 U.S. health systems to support safer, more consistent glycemic management at the bedside.
Elevate your practice with our innovative diabetes management platform
Ready to see how Glooko can elevate your clinic? Schedule a meeting with one of our experts at DTC25.
EndoTool is developed and marketed by Monarch Medical Technologies, a Glooko Company. EndoTool is an FDA-cleared Class II medical device indicated for inpatient use as described in its Instructions for Use. Glooko’s diabetes management platform and EndoTool are currently independent solutions. Patient-specific refers to EndoTool’s ability to use available patient information within the hospital’s electronic medical record to provide individualized insulin dosing recommendations. Recommendations are intended to assist, not replace, clinical judgment. All treatment decisions remain the responsibility of the licensed healthcare provider.